Your browser doesn't support javascript.
loading
Validity of Cancer Antigen-125 (CA-125) and Risk of Malignancy Index (RMI) in the Diagnosis of Ovarian Cancer.
Al-Musalhi, Khawla; Al-Kindi, Manal; Ramadhan, Fatma; Al-Rawahi, Thuraya; Al-Hatali, Khalsa; Mula-Abed, Waad-Allah.
Affiliation
  • Al-Musalhi K; Department of Chemical Pathology, Royal Hospital, Muscat, Oman.
  • Al-Kindi M; Department of Chemical Pathology, Royal Hospital, Muscat, Oman.
  • Ramadhan F; Department of Histopathology, Royal Hospital, Muscat, Oman.
  • Al-Rawahi T; Department of Obstetrics and Gynecology, Royal Hospital, Muscat, Oman.
  • Al-Hatali K; Department of Obstetrics and Gynecology, Royal Hospital, Muscat, Oman.
  • Mula-Abed WA; Department of Chemical Pathology, Royal Hospital, Muscat, Oman.
Oman Med J ; 30(6): 428-34, 2015 Nov.
Article in En | MEDLINE | ID: mdl-26675326
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Oman Med J Year: 2015 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Oman Med J Year: 2015 Document type: Article